Wed, 18 Jan 2017 15:21:00 GMTIn this issue: India’s new drug pricing policy, bringing transparency to pharma industry payments, a UK innovation centre enabling new means of drug discovery, how artificial intelligence is being used in drug development, and more.
Wed, 18 Jan 2017 13:55:00 GMTOptima Pharma has announced that it will be presenting its MultiUse Filler series during a 3D cinema show at INTERPHEX at the Javits Center, New York.
Wed, 18 Jan 2017 00:00:00 GMTCancer Research UK, Cancer Research Technology (CRT) and MRC Technology are set to collaborate in a bid to focus on cancer immunotherapies.
Wed, 18 Jan 2017 00:00:00 GMTUS-based men’s cancer survivor support and advocacy national non-profit organisation Malecare has launched a new mobile application, Cancergraph, which tracks cancer symptoms.
Wed, 18 Jan 2017 00:00:00 GMTEisai has acquired the rights for manufacturing active pharmaceutical ingredients (API) for Japan from F Hoffman-La Roche for the insomnia treatment / anaesthesia induction agent flunitrazepam.
Tue, 17 Jan 2017 14:56:00 GMTMalvern has announced it will host a webinar to discuss how to measure zeta surface potential.
Tue, 17 Jan 2017 14:35:00 GMTDrug formulation, an integral step in the regulated pharmaceutical industry, involves the careful blending and processing of precisely specified and measured components to create a final product that can be administered to deliver the required clinic…
Tue, 17 Jan 2017 12:24:00 GMTAt Pharmapack in Paris, Schreiner MediPharm will be presenting its extensive portfolio of customised pharmaceutical security solutions to safeguard the supply chain in Hall 4, Stand M31.
Tue, 17 Jan 2017 10:08:00 GMTShowcasing from the 1 February to 2 February, the company will be present at stand L51 to greet visitors and discuss projects
Tue, 17 Jan 2017 00:00:00 GMTDrug approval body the Scottish Medicines Consortium (SMC) has rejected two life-prolonging indications of new myeloma drugs, Kyprolis (carfilzomib) and Darzalex (daratumumab), for use in the country.
Tue, 17 Jan 2017 00:00:00 GMTThe European Commission (EC) has amended the marketing authorisation for Netherlands-based Pharming Group’s Ruconest (recombinant C1 esterase inhibitor) to include self-administration using the Ruconest administration kit.
Tue, 17 Jan 2017 00:00:00 GMTA new study from the University of Eastern Finland has found the use of drugs such as benzodiazepine and benzodiazepine-like drugs was related to a 20% increased risk of stroke in patients with Alzheimer’s disease.
Mon, 16 Jan 2017 14:26:00 GMTWorker Preferences and Workplace Agility canvasses the value employees attach to key elements of their work, including skills, flexible work arrangements, and even the idea of socially conscious work.
Mon, 16 Jan 2017 13:15:00 GMTSHL has announced that it will exhibit at Pharmapack Europe in Paris Expo Porte de Versailles Hall 4.
Mon, 16 Jan 2017 09:12:00 GMTGlobal provider of essential healthcare packaging and support services Essentra aims to exceed client expectations time and time again with its commitment to innovation and meeting the rapidly changing requirements of the healthcare and pharmaceutica…
Mon, 16 Jan 2017 00:00:00 GMTThe US Food and Drug Administration (FDA) has extended the review period for the new drug application (NDA) for Eli Lilly and Incyte’s investigational baricitinib used to treat patients suffering from moderate-to-severe rheumatoid arthritis (RA).
Mon, 16 Jan 2017 00:00:00 GMTA Europe-wide initiative bringing transparency to pharma industry payments to healthcare professionals and organisations has prompted a spirited debate across the continent. Ireland is no exception, with critics questioning the €27.2m paid to public …
Mon, 16 Jan 2017 00:00:00 GMTCanadian-headquartered M Pharmaceutical has announced plans to continue advancing the development of a topical drug product as part of its planned acquisition of 40 J's.
Mon, 16 Jan 2017 00:00:00 GMTMerck has collaborated with Palantir to leverage the latter’s advanced data analytics capabilities to help it develop and deliver medicines to patients.
Fri, 13 Jan 2017 11:21:00 GMTManaging Director Fred Cremer has transferred his controlling interest in Cremer Speciaalmachines to Uhlmann Pac-Systeme & Co in Germany.